Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer | Journal for ImmunoTherapy of Cancer User montaukwhaler, in the non small cell lung cancer subreddit, 13 Feb 2019